GERON CORP Short-Term Debt
GERON CORP (GERN) had Short-Term Debt of $0 as of 2025-03-31, per its 10-Q filed 2025-05-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:DebtCurrent · last filed 2025-05-07
- 2025-03-31: Debt, Current $0.00.
- 2024-12-31: Debt, Current $0.00.
- 2024-09-30: Debt, Current $71.56M.
- 2024-06-30: Debt, Current $46.92M.
| Period end | Debt, Current |
|---|---|
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 |
| 2024-12-31 | $0.00 10-Q · filed 2025-05-07 |
| 2024-09-30 | $71.56M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $46.92M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $71.53M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $46.89M 10-K · filed 2025-02-27 |
| 2023-09-30 | $22.06M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $10.84M 10-Q · filed 2023-08-03 |
| 2022-12-31 | $20.95M 10-K · filed 2024-02-28 |
| 2022-09-30 | $12.96M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $5.16M 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |